Clinical Trials

A profound shift in understanding the genetic roots of hypermobile Ehlers–Danlos syndrome is underway, as a landmark study dismantles the long-standing theory of a single-gene cause for this complex and often debilitating condition. For decades, the search for a solitary genetic culprit has left

In the highly competitive world of biopharmaceuticals, where fortunes can shift with a single clinical trial update, Nektar Therapeutics has delivered a powerful reminder of the value of persistence and innovative science. The company's shares experienced a dramatic upward trajectory after it

An experimental oral medication for obesity has delivered substantial weight loss in a mid-stage trial, heralding the arrival of a formidable new challenger in a market dominated by pharmaceutical titans. Co-developed by Hengrui Pharma and Kailera Therapeutics, the pill, known as ribupatide,

The integration of advertising into conversational AI platforms like ChatGPT is poised to subtly yet profoundly reshape how patients discover and consider clinical research, representing not a radical upheaval but a significant evolutionary step in digital communication. This development marks a

The long-held view of enzymes as nature's exquisitely specific but single-minded catalysts is undergoing a profound transformation, giving way to a new paradigm that reimagines them as versatile, programmable molecular machines. This significant shift, fueled by remarkable discoveries in natural

Today we're joined by Ivan Kairatov, a biopharma expert with a deep understanding of the innovations shaping cancer research. His work delves into one of the most challenging frontiers in oncology: the intricate relationship between the nervous system and pancreatic cancer. We'll explore how